Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. According to the site of the primary defect, the CMS can be classified as presynaptic, synaptic, or postsynaptic. The postsynaptic CMS identified to date are characterized by a kinetic abnormality of the acetylcholine receptor (AChR) with or without AChR deficiency, or by AChR deficiency without a primary kinetic abnormality. We hypothesized and subsequently confirmed that a kinetic abnormality of the AChR at the single-channel level predicts a mutation in an AChR subunit gene, and that a severe deficiency of AChR can stem from nonsense mutations in AChR subunit genes. Seven dominant slow-channel mutations in different subunits and different domains of the subunits have been identified thus far. Mutations in the M2 and M1 transmembrane domains act predominantly by slowing channel closure, and mutations in M2 also allow spontaneous channel opening. Another slow-channel mutation in the extracellular domain of the α-subunit acts predominantly by enhancing the affinity of AChR for ACh, causing repeated channel reopenings during a prolonged ACh occupancy. The recently discovered low-affinity fast-channel syndrome is the physiologic opposite of the slow-channel syndrome. Here, a mutation in the extracellular domain of the ε-subunit reduces the affinity of AChR for ACh; this decreases the rate of channel opening, and results in briefer than normal bursts of openings. Finally, a number of homozygous or heterozygous nonsense mutations in an AChR subunit cause severe AChR deficiency.

Original languageEnglish (US)
JournalNeurology
Volume48
Issue number4 SUPPL. 5
StatePublished - 1997

Fingerprint

Congenital Myasthenic Syndromes
Cholinergic Receptors
Mutation
Genes
Nonsense Codon

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes. / Engel, Andrew G; Ohno, Kinji; Milone, Margherita; Sine, Steven M.

In: Neurology, Vol. 48, No. 4 SUPPL. 5, 1997.

Research output: Contribution to journalArticle

@article{9a4a33afbd2d4e24b3242ab35fe516ea,
title = "Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes",
abstract = "Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. According to the site of the primary defect, the CMS can be classified as presynaptic, synaptic, or postsynaptic. The postsynaptic CMS identified to date are characterized by a kinetic abnormality of the acetylcholine receptor (AChR) with or without AChR deficiency, or by AChR deficiency without a primary kinetic abnormality. We hypothesized and subsequently confirmed that a kinetic abnormality of the AChR at the single-channel level predicts a mutation in an AChR subunit gene, and that a severe deficiency of AChR can stem from nonsense mutations in AChR subunit genes. Seven dominant slow-channel mutations in different subunits and different domains of the subunits have been identified thus far. Mutations in the M2 and M1 transmembrane domains act predominantly by slowing channel closure, and mutations in M2 also allow spontaneous channel opening. Another slow-channel mutation in the extracellular domain of the α-subunit acts predominantly by enhancing the affinity of AChR for ACh, causing repeated channel reopenings during a prolonged ACh occupancy. The recently discovered low-affinity fast-channel syndrome is the physiologic opposite of the slow-channel syndrome. Here, a mutation in the extracellular domain of the ε-subunit reduces the affinity of AChR for ACh; this decreases the rate of channel opening, and results in briefer than normal bursts of openings. Finally, a number of homozygous or heterozygous nonsense mutations in an AChR subunit cause severe AChR deficiency.",
author = "Engel, {Andrew G} and Kinji Ohno and Margherita Milone and Sine, {Steven M}",
year = "1997",
language = "English (US)",
volume = "48",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4 SUPPL. 5",

}

TY - JOUR

T1 - Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes

AU - Engel, Andrew G

AU - Ohno, Kinji

AU - Milone, Margherita

AU - Sine, Steven M

PY - 1997

Y1 - 1997

N2 - Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. According to the site of the primary defect, the CMS can be classified as presynaptic, synaptic, or postsynaptic. The postsynaptic CMS identified to date are characterized by a kinetic abnormality of the acetylcholine receptor (AChR) with or without AChR deficiency, or by AChR deficiency without a primary kinetic abnormality. We hypothesized and subsequently confirmed that a kinetic abnormality of the AChR at the single-channel level predicts a mutation in an AChR subunit gene, and that a severe deficiency of AChR can stem from nonsense mutations in AChR subunit genes. Seven dominant slow-channel mutations in different subunits and different domains of the subunits have been identified thus far. Mutations in the M2 and M1 transmembrane domains act predominantly by slowing channel closure, and mutations in M2 also allow spontaneous channel opening. Another slow-channel mutation in the extracellular domain of the α-subunit acts predominantly by enhancing the affinity of AChR for ACh, causing repeated channel reopenings during a prolonged ACh occupancy. The recently discovered low-affinity fast-channel syndrome is the physiologic opposite of the slow-channel syndrome. Here, a mutation in the extracellular domain of the ε-subunit reduces the affinity of AChR for ACh; this decreases the rate of channel opening, and results in briefer than normal bursts of openings. Finally, a number of homozygous or heterozygous nonsense mutations in an AChR subunit cause severe AChR deficiency.

AB - Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. According to the site of the primary defect, the CMS can be classified as presynaptic, synaptic, or postsynaptic. The postsynaptic CMS identified to date are characterized by a kinetic abnormality of the acetylcholine receptor (AChR) with or without AChR deficiency, or by AChR deficiency without a primary kinetic abnormality. We hypothesized and subsequently confirmed that a kinetic abnormality of the AChR at the single-channel level predicts a mutation in an AChR subunit gene, and that a severe deficiency of AChR can stem from nonsense mutations in AChR subunit genes. Seven dominant slow-channel mutations in different subunits and different domains of the subunits have been identified thus far. Mutations in the M2 and M1 transmembrane domains act predominantly by slowing channel closure, and mutations in M2 also allow spontaneous channel opening. Another slow-channel mutation in the extracellular domain of the α-subunit acts predominantly by enhancing the affinity of AChR for ACh, causing repeated channel reopenings during a prolonged ACh occupancy. The recently discovered low-affinity fast-channel syndrome is the physiologic opposite of the slow-channel syndrome. Here, a mutation in the extracellular domain of the ε-subunit reduces the affinity of AChR for ACh; this decreases the rate of channel opening, and results in briefer than normal bursts of openings. Finally, a number of homozygous or heterozygous nonsense mutations in an AChR subunit cause severe AChR deficiency.

UR - http://www.scopus.com/inward/record.url?scp=0030898407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030898407&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030898407

VL - 48

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4 SUPPL. 5

ER -